Pharmaceutical Market Trends Key market forecasts growth opportunities Edition

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Anti-Infective Drug News 23 FEBRUARY 2015

Anti-Infective Drug News 23 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 16 pages

Industry Trend Analysis - HIV Market Set To Expand Gradually; Gilead To Uphold Leadership Despite ViiV Industry Brief - Affinivax/PATH Collaborate To Advance Vaccine Candidate For Pneumococcus Industry Brief - Valneva Completes Acquisition Of Dukoral Vaccine From Crucell Industry Brief - NICE Sets Out ...

Industries: Drug and Medication | Countries: United States, Canada, Japan, India

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • by BCC Research
  • February 2015
  • 123 pages

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019. This report provides: An overview of the global markets ...

Industries: Pathology | Countries: World, Japan, Europe, United States

Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • February 2015
  • 156 pages

BMI View: Japan’s pharmaceutical industry is highly attractive to both foreign and local drugmakers. All three sub-sectors – patented, generic and over-the-counter (OTC) medicines – are large and projection to growth over the medium term. Regulations are well-developed, transparent and improving. ...

Industries: Drug and Medication | Countries: Japan

Cancer Drug News 16 FEBRUARY 2015

Cancer Drug News 16 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 16 pages

Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio Industry Brief - Kinex Licenses BCRP-Targeted Patents From Hong Kong Polytechnic University/McGill University Industry Brief - Lion Obtains Licence From NIH To Develop TIL Therapy In MM Industry Trend ...

Industries: Drug and Medication | Countries: United States, Brazil, Japan, China, World

The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

  • $ 2 500
  • Industry report
  • by SNS Telecom
  • February 2015
  • 249 pages

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Already prevalent in the U.S., Europe and much of ...

Industries: Generic Drug | Countries: World, Europe, Japan, South Korea, India, Asia, United States, North America, Canada, China, Africa, Netherlands, Saudi Arabia, South Africa

Key Pharma News 16 FEBRUARY 2015

Key Pharma News 16 FEBRUARY 2015

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 41 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis Industry Trend Analysis - Acquisition ...

Industries: Pathology | Countries: Japan, World, United States, Russian Federation, China

Generic Drugs Market in Japan 2015-2019

Generic Drugs Market in Japan 2015-2019

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • February 2015
  • 94 pages

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. ...

Industries: Generic Drug | Countries: Japan

Anti-Infective Drug News 09 FEBRUARY 2015

Anti-Infective Drug News 09 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian Generics Companies Industry Trend Analysis - Novartis Vaccine Business Picks Up Owing To Expanding Meningitis Market; Well-Timed For GSK Industry Brief - Takeda Discontinues Phase II Programme For DTaP/sIPV ...

Industries: Drug and Medication | Countries: Japan, India, United States, World

Cancer Drug News 02 FEBRUARY 2015

Cancer Drug News 02 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - OncoMed's Latest ODD Highlights Anti-CSC Potential Industry Brief - DSMB Recommends Continuation of Masitinib Phase II Study In Relapsed BC Industry Trend Analysis - Amgen's Filings For Kyprolis In MM Will Not Affect Celgene's Product Sales Industry Brief - MacroGenics/Janssen ...

Industries: Drug and Medication | Countries: United States, Japan

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market : Discovery of New Targeted Therapies will Replace Conventional Therapies

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • January 2015
  • 74 pages

Executive Summary •The estimated market size for lung cancer therapeutics in 2014 was $ x billion. •There is increasing competition in this market, especially amongst the large pharmaceutical (pharma) participants such as Merck, AstraZeneca, Eli Lilly, and Bristol-Myers Squibb (BMS), which are set ...

Industries: Therapy | Countries: China, Japan, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.